Zota Health Care Ltd

ZOTA Stock View

(NSE)

276.00

696.82
Proj. ROE (%)
-
Proj. P/E (x)
-
Proj EV / EBITDA (x)
-
Proj. P/BV (x)
-
Proj. Revenue ( Cr.)
-

Stock View

-
Share on
The average score for Zota Health Care Ltd stands at 3 against 3, three months back.

Zota Health Care Limited is an India-based company, which is engaged in drug development, manufacturing and marketing. The Company offers a portfolio consisting of a range of pharmaceutical, nutraceutical, as well as ayurvedic products in India and abroad. Its domestic products include Acarbose 25/50 mg, Aceclofenac 100 mg + Paracetamol 325 mg, Aceclofenac 100 mg , Aceclofenac 200 mg SR, Albendazole 400 mg + Ivermectin 6 mg, Amilsupride 50/100/200 mg, Amitriptyline HCL 10/25 mg, and others. Its imternational products include Artemether 20/80 MG + Lumifentine 120/480 mg, Atenolol 50/100 mg, Atorvastatin 10 mg + Fenofibrate 160 mg Tab, Atorvastatin 10/20/40 mg Tab, Betahistine 16 mg Tab, Bromhexine 8 mg, Calcium 500 mg + Vit D3 250 IU, Carbamazepine 200 mg, Cetrizine 10 mg, Chlorpheniramine Maleate 4 mg, Cimetidine 200/400 mg, Citicoline 500 mg, Clopidogrel 75 mg, Clozapine 100 mg, Desloratidine 5 mg, Domperidone 10 mg DT, Escitalopram 10 mg, Finasteride 5mg, and others.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
267.08
100 DMA ()
285.24
200 DMA ()
329.50
52 Weeks Range
224.95
448.00
Street View :-
Bearish
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity